Gastrografin and Nausea aggravated - a phase IV clinical study of FDA data

Summary:

Nausea aggravated is reported as a side effect among people who take Gastrografin (diatrizoate meglumine; diatrizoate sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ultravist 300, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Nausea aggravated when taking Gastrografin. It is created by eHealthMe based on reports of 519 people who have side effects when taking Gastrografin from the FDA, and is updated regularly.

What is Gastrografin?

Gastrografin has active ingredients of diatrizoate meglumine; diatrizoate sodium. eHealthMe is studying from 523 Gastrografin users. Check the latest studies of Gastrografin.

What is Nausea aggravated?

Nausea aggravated (an urge to vomit) is found to be associated with 3,410 drugs and 1,083 conditions by eHealthMe. Check the latest studies of Nausea aggravated.

On Jul, 29, 2026

519 people reported to have side effects when taking Gastrografin.
Among them, 35 people (6.74%) have Nausea aggravated.

Could Gastrografin cause Nausea aggravated?

Among these 35 people:

How long have people been on Gastrografin when they have Nausea aggravated? *

What is the gender of people who have Nausea aggravated when taking Gastrografin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Nausea aggravated when taking Gastrografin? *

What are other drugs people take besides Gastrografin? *

Zofran: 7 people, 20.00%
Ultravist 300: 7 people, 20.00%
Vancomycin: 5 people, 14.29%
Acetylcysteine: 5 people, 14.29%
Isosorbide Mononitrate: 5 people, 14.29%
Protonix: 4 people, 11.43%
Hydrocortisone: 4 people, 11.43%
Tylenol: 4 people, 11.43%
Meropenem: 4 people, 11.43%
Dilaudid: 4 people, 11.43%

What are other side effects people have besides Nausea aggravated? *

Nausea And Vomiting: 15 people, 42.86%
Diarrhea: 11 people, 31.43%
Abdominal Pain: 9 people, 25.71%
Hypotension (abnormally low blood pressure): 6 people, 17.14%
Agitation (state of anxiety or nervous excitement): 6 people, 17.14%
Cough: 6 people, 17.14%
Fever: 6 people, 17.14%
Oedema Peripheral (superficial swelling): 5 people, 14.29%
Insomnia (sleeplessness): 5 people, 14.29%
Arrhythmias (irregular heartbeat): 5 people, 14.29%

What are the existing conditions these people have? *

Computerised Tomogram Abdomen: 10 people, 28.57%
Pain: 4 people, 11.43%
High Blood Pressure: 3 people, 8.57%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.57%
Dyspnea (difficult or laboured breathing): 3 people, 8.57%
Headache (pain in head): 2 people, 5.71%
Haematopoietic Stem Cell Mobilisation: 2 people, 5.71%
Fever: 2 people, 5.71%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 5.71%
Diarrhea: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Gastrografin and have Nausea aggravated?

- Check whether Nausea aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gastrografin:

Gastrografin (523 reports)

Nausea aggravated treatments and more:

Nausea aggravated (214 reports)

How severe was Nausea aggravated and when was it recovered:

Nausea aggravated in Gastrografin

Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:

Nausea aggravated and drugs with ingredients of diatrizoate meglumine; diatrizoate sodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gastrografin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea aggravated:

Nausea aggravated (3,410 drugs)

Browse all the conditions that are associated with Nausea aggravated:

Nausea aggravated (1,083 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Gastrografin) and Gastrografin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.